Cora's licensed physicians review every patient assessment before prescribing
Good candidates are typically those with a BMI of 30 kg/m2 or higher, or a BMI of 27 kg/m2 with a weight-related health condition, who are committed to a supervised program of diet and exercise
That means no increase in IGF-1 production, no effect on blood glucose, no insulin resistance, no water retention, and no risk of the organ growth associated with full HGH therapy
Early clinical trials have shown promising results, with agents like semaglutide and exenatide demonstrating reductions in alcohol consumption and craving, as well as potential benefits for smoking cessation, such as reduced post-cessation weight gain
Enhanced Metabolic Functions : Anticipate improvements in blood sugar levels, cholesterol, and blood pressure as part of your tirzepatide treatment